
16 Apr 2024
First Take: Oxford Instruments - Positive momentum, FY24 in-line
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
First Take: Oxford Instruments - Positive momentum, FY24 in-line
Oxford Instruments plc (OXIG:LON) | 1,794 -502.3 (-1.5%) | Mkt Cap: 1,036m
- Published:
16 Apr 2024 -
Author:
Ben Bourne | Scott Cagehin | Lydia Kenny -
Pages:
4 -
Oxford Instruments has released a positive H2 trading update. Key highlights include positive organic growth and momentum, margins to be c.100bps lower y-o-y (this is slightly ahead of consensus), and FY24 profit to be in-line with expectations.
Trading summary
H2 trading was as anticipated with FY24 revenues expected to be 6% higher y-o-y (+9% at cc) reflecting positive momentum and driven by growth in all geographies and key end markets, including advanced materials, life science and semiconductors.
Orders were lower y-o-y against tough comparators and a slowdown in life science OEM orders, however the book-to-bill remains positive.
Outlook
FY24 operating profit is anticipated to be in-line with expectations (INVe £77.3m – FactSet consensus £77.2m) with FY24 margins set to be c.100bps lower y-o-y (consensus -130bps) due to China losses and operational investment.
The group enters FY25 with a strong order book and a robust growth pipeline while cost actions should support profits.
Next catalysts – FY24 results are scheduled on 11 June 2024 and a site visit on 10 July 2024 to its new operational etch and deposition systems facility in Bristol, focusing on the product and services provided within the compound semiconductor industry.